Fluzos 250 mg injection is a prescription medicine containing Fulvestrant (250/5 ml) , used to treat HR-positive ,HER2-negative metastatic breast cancer in postmenopausal women . it is an estrogen receptor antagonist that works by blocking and degrading estrogen receptors, slowing cancer growth . it works as an estrogen blocker. It binds to estrogen receptors, causing them to degrade , which reduces the amount of estrogen available to fuel the growth of cancer cells.
Hormonal therapy treats cancer that rely on hormones to grow-primarily breast and prostrate cancers by stopping or reducing hormone production or blocking their action. It is highly effective for reducing hormone production or blocking their action. It is highly effective for reducing recurrence risk after surgery, shrinking tumors before treatment or treating metastatic disease.
WHAT IS FLUZOS 250 MG?
Fluzos 250 mg injection is classified as an antineoplastic agent and specifically act as an estrogen receptor antagonistic. It works by blocking and degrading estrogen receptors to treat HR_positive /HER2-negative metastatic breast cancer in postmenopausal women .
Key classification :
- · Active ingredient : Fulvestrant
- Therapeutic class: antineoplastic/hormone therapy
- · Mechanism: it works by binding to blocking, and degrading estrogen receptors, preventing the hormone from fueling cancer growth
- · Administration : it is administred via intramuscular injection ,commonly under the brand name Fulzos ,manufactured by Hetero Healthcare .
WHAT ARE THE MEDICAL USES OF FLUZOS 250 MG INJECTION ?
Medical uses of Fluzos 250 mg injection are:
1. Treatment of hormone receptor –positive breast cancer
Fluzos 250 mg injection is a hormonal therapy used to treat hormone receptor –positive (HR+) , HER2_negative advanced or metastatic breast cancer in postmenopausal women. It works by binding to and degrading estrogen receptors , blocking estrogen from fueling cancer growth. It is administered via intramuscular injection ,often at 500 mg dose . it act as an estrogen receptor antagonist and downregulator, meaning it blocks the receptors and tiggers its degradation .
2. Advanced or metastatic breast cancer
Fluzos is a hormone therapy used to treat hormone receptor –positive (HR+) ,HER2 –negative advanced or metastatic breast cancer in postmenopausal women. It works by blocking and degrading estrogen receptors, slowing tumor growth. The medication is administrated as an intramuscular injection . it is given as an injection in to the buttock muscle by a healthcare professional . it may be used alone or in combination with other anti-cancer medications , such as CDK4/6 inhibitor like palbociclib.
3. Used in postmenopausal women
Fluzos injection is a hormonal therapy used to treat hormone receptor-positive (HR+) ,HER2- negative advanced or metastatic breast cancer in postmenopausal women . it works as an estrogen receptor antagonist that binds to ,blocks and degrades estrogen receptors, slowing down the growth of cancer cells.
4. Often combined with other targeted therapies
Fluzos 250 mg is an estrogen receptor antagonist used to treat HR-positive , HER2-negative advanced breast cancer ,commonly combined with CKD 4/6 Inhibitors or p13k inhibitors like alpelisb , particularly after progression on prior endocrine therapy. With less common than targeted agents, it has been studied with aromatase inhibitors like anastrozole.
WHAT ARE THE BENEFITS OF FULOZ 250 MG INJECTION?
Benefits of Fuloz 250 mg injection are:
1. Targets estrogen –driven cancer cells
Fluoz is a targeted hormone therapy used for estrogen receptor-positive (ER+) ,HER –negative advanced or metastatic breast cancer in postmenopausal women. It works by blocking and degrading estrogen receptors, preventing the hormone from fueling cancer cells. As a selective estrogen receptor Degrader (SERD) , it binds to estrogen receptors, causing them to breakdown ,which reduces the number of receptors available for cancer cells to use.
2. Helps slow disease progression
Fluoz injection contains fulverstrant, which is used to slow or halt the growth of advanced or metastatic hormone receptor –positive (HR+) breast cancer in postmenopausal women . it works by blocking estrogen and accerlating the degradation of estrogen receptor ,which fuels the cancer. It works by interfering with the growth of cancer cells, helping to slow or stop them from multiplying.
3. Effective in advanced stages of breast cancer
Fluoz is a medication used to treat certain types of advanced hormone receptor –positive (HR+ ) breast cancer ,typically utilized in postmenopausal women . it functions by binding to and degrading estrogen receptors in cancer cells. The drug was initially approved for postmenopausal women with HR+ metastatic breast cancer whose disease progressed after previous antiestrogen therapy. It is often used in combination with targeted therapies , such as CDK44/6 inhibitors for the management of advanced disease.
4. Can be used when other hormone therapies fail
Fluoz is a non steroid antianderogen used in the treatment of advanced prostrate cancer ,particularly when initial hormone therapies such as LHRH agoinists or surgical castration have not successfully controlled the disease . it functions by blocking androgen receptors on tumor cells to help inhibit cancer growth.
WHAT ARE THE POSSIBLE SIDE EFFECTS OF FLUOZ 250 MG INJECTION?
Possible side effects of Fluoz 250 mg injection are:
1. Injection site pain
2. Nausea
3. Fatigue
4. Hot flashes
5. Joint or muscle pain
CONCLUSION
Based on clinical trails, fulzos 250 mg is superior in treating hormone –receptor –positive (HR+) advanced breast cancer. Fluzos 250 mg is still recognised as an effective alternative to antrazole in postmenopausal women with advanced breast cancer who have progressed on prior endocrine therapy. It is often used in studies and clinical practice as a base endocrine partner for targated therapies in HR+/HER2_pateints.
FREQUENTLY ASKED QUESTIONS (FAQs):
QUESTION: HOW LONG IS FLUZOS TREATMENT CONTINUED?
Fluoz 250 mg is typically administered to treat hormone receptor –positive metastatic breast cancer in postmenopausal women . treatment continues for as long as the cancer responds to the medication. With the goal of slowing or preventing disease progression, rather than a fixed number of cycles .
QUESTION: CAN FLUOZ BE COMBINED WITH OTHER CANCER DRUGS?
Yes, Fluoz 250 mg is frequently combined with other cancer treatments , most commonly radiotherapy , for newly diagnosed gilobalstoma multiforme. It is an oral alkylating agent used for brain tumors followed by monotherapy, or as part of combination therapy plans with
other agents.
REFRENCES :
1.https://www.apothecare.in/products/glioz-250mg-capsule
2.https://www.apollopharmacy.in/medicine/glioz-250mg-cap-5-s?srsltid=AfmBOoptOKAZGh87ZKnQk7WkIcJPcQdThfqr4F0bNJjqea-U0P4UAN_x
